We are renowned for managing complex patent disputes. Our reputation has been built with the support of clients - both plaintiffs and defendants - across hundreds of cases.
Our expertise enables us to assist clients in navigating specialised procedures, including infringement seizures, preliminary injunctions, patent infringement actions, patent nullification actions, and non-infringement declarations. We also assist clients with alternative dispute resolution, including mediation and arbitration.
Supplementary Protection Certificate
With extensive experience in the pharmaceutical sector, our team has been involved in the majority of French and European litigated cases concerning Supplementary Protection Certificates.
We leverage our expertise to offer our clients innovative solutions in line with French and European jurisprudence.
Our team provides advice to clients involved in negotiations and disputes concerning Standard-Essential Patents.
Notably, we secured the first decision recognising the jurisdiction of French courts to deal with a request to determine a FRAND rate in a dispute involving the ETSI.
We have broad expertise on the use and misuse of know-how.
We regularly advise clients on how best to protect and manage know-how in various contexts, including recruitment, employment, development agreements, and corporate transactions.
We also act in litigation before French courts and arbitration tribunals on matters involving know-how disputes. This includes seizures based on the provisions of Article 145 of the Code of Civil Procedure.
We are widely recognised in the life sciences field for both our technical and legal expertise. We leverage this dual capability to advise clients on related issues, including regulatory law and civil liability.
Our understanding of life sciences, biotechnologies, and the pharmaceutical industry at large allows us to assist clients in diverse areas, including data exclusivity, generic medicines, procedures before the European Medicines Agency, clinical trials, medical devices, orphan drugs, pharmaceutical advertising, and product liability.
We are commited to identifying novel solutions to our clients legal challenges, including approaches that leverage competition law. We have built a network of leading, specialised law firms who we work with in bringing and responding to actions before the French Competition Authority and the European Commission.